Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Mingot-Castellano ME; Pardos-Gea J; Rico AM; Alcalde-Mellado P; Salvadores-Alvares V; Jimenes AJ; Hirnyk MC; Gutierrez AB; Bastida JM; Alén JAR; Candel FG; Penella DT; Quintana AM; Navarro GAM; Palmer ER; Expósito MC; Correa SA; Miñana LT; Garcia JAR; Alvarez-Roman MT; Garcia RL; Gonzalez RR; Antoran JMM; Escobar NA; Culebras RA; Badás MPM; Antonio SM; Barrientos MU; Mosteirin NF; Sanchez MP; Herrero SV; Santiago CC; Miranda IC; Mañas MAP; Fernandez IV; Izquierdo CP; Lopez SC; Vera PM.

Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR).

HAEMATOLOGICA. 2026; 111(2): 756-759 [doi:10.3324/haematol.2025.288480]

Bailén, R; Fernández-Villalobos, M; Alonso, S; Gómez-Centurión, I; Fernández-Caldas, P; Castilla, L; Llácer, MJ; Ahumada, A; Iniesta, C; Rincón, D; Muñoz, C; Sabell, S; Carbonell, D; Anguita, J; García-Sanz, R; Bañares, R; Kwon, M.

Prognostic value of liver stiffness measurement for complications after allogeneic transplant with post-transplant cyclophosphamide

Frontiers in Immunology. 2026; 16: 1699219-1699219 [doi:10.3389/fimmu.2025.1699219]

Pérez-Lamas, L; Manzanares, M; Boluda, JCH; Montero, LFC; Casares, MTG; Ayala, R; Xicoy, B; Marin, FF; Ortí, G; Arias, RD; Prendes, SO; Lopez, RP; Mora, E; Nuño, CR; Velasco, AJ; Boqué, C; Pacho, MS; Lopez, JM; Carreño-Tarragona, G; Coiras, M; Garcia-Gutierrez, V.

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib

ANNALS OF HEMATOLOGY. 2026; 105(2): [doi:10.1007/s00277-026-06806-7]

Rosa, AA; Carolina, AP; Marta, AV; Francisco, A; Adriana, FG; Natalia, G; Pablo, LL; Cristina, MF; Lydia, MS; Ulrike, N; Marina, S; Guillermo, HT; Henar, CG; Ana, GOD.

Experience of a Referral Center with Desmoid Tumors, Part 2: A Retrospective Analysis of 109 Cases

Cancers. 2026; 18(2): [doi:10.3390/cancers18020305]

Rodríguez, BH; Navarro, PG; González, PV; Colino, CG.

Experience in the approach to adolescents with cancer in a multidisciplinary unit. Growing together

EUROPEAN JOURNAL OF PEDIATRICS. 2026; 185(2): [doi:10.1007/s00431-026-06747-3]

García-Vicente, R; Rodríguez-García, A; Ancos-Pintado, R; Arroyo, A; Ortega-Hernández, A; Bragado-García, I; Castellano, E; Ortiz-Ruiz, A; Navarro-Aguadero, MA; Modrego, J; Leivas, A; García-Villalba, R; Tomás-Barberán, FA; Sánchez-Pina, JM; Alonso, R; Cedena, MT; Hernández-Sánchez, M; Carpio, C; Barba, P; Carbonell, D; Kwon, M; Bastos-Oreiro, M; García-Sancho, AM; Jiménez-Ubieto, A; Valeri, A; Gómez-Garre, D; Martínez-López, J; Linares, M.

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma

CLINICAL CANCER RESEARCH. 2026; 32(2): 375-389 [doi:10.1158/1078-0432.CCR-25-1676]

Lozano-Gil, JM; Rodríguez-Ruiz, L; Palacios, M; Peral, J; Navarro, S; Fuster, JL; Beléndez, C; Jérez, A; Murillo-Sanjuán, L; Díaz-de-Heredia, C; López-de-Hontanar, G; Zubicaray, J; Sevilla, J; Ferrer-Marín, F; Sepulcre, MP; Cayuela, ML; García-Moreno, D; Martínez-López, A; Tyrkalska, SD; Mulero, V.

TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome

EMBO MOLECULAR MEDICINE. 2026; 18(2): 702-724 [doi:10.1038/s44321-025-00368-3]

García-Cadenas, I; Guerreiro, M; Yañez, L; Chorao, P; Martin, F; Suárez-Lledó, M; Pérez, A; Tomás, LG; López, J; Marsal, J; Romero, N; Huguet, M; Zabalza, A; González-Vicent, M; Vázquez, L; Silva, P; Gil, D; Micó-Cerdà, M; Sánchez, P; Filaferro, S; Balsalobre, P; Ubieto, AJ; Martino, R; Piñana, JL.

Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study

EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(4): 450-457 [doi:10.1111/ejh.70109]

Fernández-Luis S; Bermúdez A; Yáñez San Segundo L; Baile González M; Marcos Asensio S; Esquirol A; García-Cadenas I; Pascual MJ; Herruzo B; Salas MQ; Alburquerque-Prieto C; Viguria-Alegría MC; Pérez A; Hernani R; Huguet Mas M; Villalba M; Martín Calvo C; Fabbri N; González-Rodriguez AP; Bailén R; García Tomás L; García Maño L; Sánchez Salinas A; Calbacho M; Bento L; Sureda Balari A.

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

TRANSPLANTATION. 2026; 110(1): 243-253 [doi:10.1097/TP.0000000000005446]

Benítez-Carabante, MI; López, AM; Oficialdegui, MLU; Bieler, CB; Romero, MP; Fornieles, MP; Fuentes, C; Enríquez, SV; Silva, GG; Duarte, ML; Hurtado, JMP; Torrent, M; García, LA; Diaz-de-Heredia, C.

Unrelated donor transplantation offers a real curative opportunity for patients with transfusion-dependent thalassaemia. A multicenter retrospective study on behalf of the Spanish group for hematopoietic transplantation and cellular therapy (GETH-TC)

CYTOTHERAPY. 2026; 28(1): 101989-101989 [doi:10.1016/j.jcyt.2025.09.012]

Duque, P; Esteban, ML; Piñeiro, P; Ortiz-Lopez, A; Moreno-Carbonell, M; Lancho, P; Calvo, A; Terradillos, E; Pascual-Izquierdo, C.

Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia

BLOOD COAGULATION & FIBRINOLYSIS. 2026; 37(1): 28-37 Nº de citas: 1 [doi:10.1097/MBC.0000000000001400]

García-Sanz, R; Owen, RG; Jurczak, W; Dimopoulos, MA; McCarthy, H; Cull, G; Opat, SS; Castillo, JJ; Kersten, MJ; Wahlin, BE; Grosicki, S; Prathikanti, R; Tian, T; Allewelt, H; Cohen, AC; Tam, CS.

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Blood Advances. 2025; 9(24): 6538-6546 [doi:10.1182/bloodadvances.2024015596]

Benito, SF; Abío, M; Bardon-Cancho, EJ; Nieto, JM; Ortega, B; González, FA; Villegas, A; Benavente, C; Ropero, P.

Importance of the 3'UTR region in globin synthesis: identification of two novel HBA1 mutations causing a-Thalassemia

ANNALS OF HEMATOLOGY. 2025; 104(12): 6169-6174 [doi:10.1007/s00277-025-06624-3]

Alegría-Carrasco, E; Jaén-Castaño, M; Delgado-Wicke, P; Zurita-Cruz, ND; Montes, N; Roy-Vallejo, E; de Cordoba-Oñate, SF; Nicolao-Gomez, A; Carracedo-Rodríguez, R; Marcos-Jiménez, A; Cardeñoso-Domingo, L; González-Alvaro, I; Fernández-Ruiz, E.

Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection

Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1713928]

Röth, A; Barcellini, W; Ademokun, C; Jang, J; Lozano, ML; Ferreiras, DV; Pascual-Izquierdo, C; Chitnis, S; Matviykiv, S; Vitaliti, A; Chen, C; Katsanou, V; Chawla, R; Al-Samkari, H.

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

AMERICAN JOURNAL OF HEMATOLOGY. 2025; 101(2): 242-254 [doi:10.1002/ajh.70147]

Herrera, AF; Ansell, SM; Zinzani, PL; Radford, J; Maddocks, K; Pinto, A; Collins, GP; Bachanova, V; Bartlett, NL; Bence-Bruckler, I; Hamadani, M; Kline, J; Mayer, J; Savage, KJ; Advani, RH; Caimi, PF; Casasnovas, RO; Feldman, T; Hess, B; Bastos-Oreiro, M; Iyengar, S; Szomor, A; Townsend, W; Andre, M; Dyczkowski, J; Havenith, K; Toukam, M; Pantano, S; Cruz, HG; Wang, LQ; Negievich, Y; Lucero, M; Wuerthner, J; Carlo-Stella, C.

Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study

Blood Advances. 2025; 9(23): 6205-6217 Nº de citas: 3 [doi:10.1182/bloodadvances.2024015600]

Bazarbachi, A; Galimard, JE; Abou Dalle, I; Labopin, M; Sanz, J; Huang, H; Mayer, J; Solano, C; Lioure, B; Griskevicius, L; Maertens, J; Itälä-Remes, M; Kaare, A; Gallego-Hernanz, MP; Bug, G; Ribera, JM; Gadisseur, A; Schmid, C; Kwon, M; Poiré, X; Coccia, P; Chacon, MJ; Baron, F; Craddock, C; Brissot, E; Nagler, A; Ciceri, F; Mohty, M.

Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP

BONE MARROW TRANSPLANTATION. 2025; 61(3): 282-293 [doi:10.1038/s41409-025-02770-4]

Gurnari, C; Makishima, H; Durmaz, A; Attardi, E; Saiki, R; Bataller, A; Sapinho, G; Gondek, L; Nannya, Y; Best, S; Krishnamurthy, P; Kong, KL; Atsuta, Y; Kasahara, S; Ohyashiki, K; Miyazaki, Y; Kanemura, N; Hiramoto, N; Versino, F; Montoro, MJ; Torres-Esquius, S; Cayuela, AJ; Lopez-Esteban, M; Martínez-Laperche, C; Awada, H; Visconte, V; DiNardo, CD; Voso, MT; Dezern, AE; Garcia-Manero, G; Kulasekararaj, AG; Maciejewski, JP; Ogawa, S.

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study

LEUKEMIA. 2025; 40(1): 178-187 Nº de citas: 2 [doi:10.1038/s41375-025-02814-0]